Your browser doesn't support javascript.
loading
Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: a phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial.
Mori, Masaaki; Hara, Takuma; Kikuchi, Masako; Shimizu, Hiroyuki; Miyamoto, Tomoyuki; Iwashima, Satoru; Oonishi, Tatsuya; Hashimoto, Kunio; Kobayashi, Norimoto; Waki, Kenji; Suzuki, Yasuo; Otsubo, Yoshikazu; Yamada, Hiroshi; Ishikawa, Chikao; Kato, Taichi; Fuse, Shigeto.
Affiliation
  • Mori M; Yokohama City University Medical Center, Yokohama, Japan. mori.phv@tmd.ac.jp.
  • Hara T; Department of Lifetime Clinical Immunology, Tokyo Medical and Dental University, Tokyo, Japan. mori.phv@tmd.ac.jp.
  • Kikuchi M; Yokohama City University Medical Center, Yokohama, Japan.
  • Shimizu H; Department of Pediatrics, Hara Children's Clinic, Tokorozawa, Japan.
  • Miyamoto T; Department of Pediatrics, Yokohama City University Hospital, Yokohama, Japan.
  • Iwashima S; Children's Medical Center, Yokohama City University Medical Center, Yokohama, Japan.
  • Oonishi T; Department of Pediatrics, Yokosuka General Hospital Uwamachi, Yokosuka, Japan.
  • Hashimoto K; Hamamatsu University School of Medicine, Hamamatsu, Japan.
  • Kobayashi N; Department of Pediatrics, Chutoen General Medical Center, Kakegawa, Japan.
  • Waki K; Department of Pediatrics, National Hospital Organization Shikoku Medical Center for Children and Adults, Zentsuji, Japan.
  • Suzuki Y; Department of Pediatrics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Otsubo Y; Department of Pediatrics, Shinsyu University School of Medicine, Matsumoto, Japan.
  • Yamada H; Department of Pediatrics, Kurashiki Central Hospital, Kurashiki, Japan.
  • Ishikawa C; Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Japan.
  • Kato T; Department of Pediatrics, Sasebo City General Hospital, Sasebo, Japan.
  • Fuse S; Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan.
Sci Rep ; 8(1): 1994, 2018 01 31.
Article in En | MEDLINE | ID: mdl-29386515
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Immunoglobulin G / Infliximab / Mucocutaneous Lymph Node Syndrome Type of study: Clinical_trials Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Sci Rep Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Artery Disease / Immunoglobulin G / Infliximab / Mucocutaneous Lymph Node Syndrome Type of study: Clinical_trials Limits: Child / Child, preschool / Female / Humans / Infant / Male Language: En Journal: Sci Rep Year: 2018 Document type: Article Affiliation country: Japón Country of publication: Reino Unido